España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
OKYO Pharma
OKYO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.11
0.02
2.29%
At close: -
$1.07
-0.04
-4.04%
After Hours: 9:20 AM EDT
Get Report
Comment
OKYO Pharma (OKYO) Forecast
News
Earnings
OKYO Pharma (OKYO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for OKYO Pharma (NASDAQ:OKYO) Stock
OKYO Pharma Stock (NASDAQ: OKYO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, February 18, 2025
HC Wainwright & Co. Reiterates Buy on OKYO Ph...
Benzinga Newsdesk
Friday, February 14, 2025
HC Wainwright & Co. Reiterates Buy on OKYO Ph...
Benzinga Newsdesk
Wednesday, February 12, 2025
OKYO Pharma Says Its Lead Asset, OK-101, Has ...
Benzinga Newsdesk
Monday, February 10, 2025
HC Wainwright & Co. Reiterates Buy on OKYO Ph...
Benzinga Newsdesk
Friday, January 31, 2025
OKYO Pharma Announced Today That It Has Been ...
Benzinga Newsdesk
Wednesday, January 29, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
OKYO Pharma shares are trading higher after t...
Benzinga Newsdesk
OKYO Pharma Anticipates Completing 48-Patient...
Benzinga Newsdesk
Wednesday, January 22, 2025
OKYO Pharma shares are trading higher after t...
Benzinga Newsdesk
OKYO Pharma Announce That It Has Received $1....
Benzinga Newsdesk
Friday, October 25, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, October 24, 2024
3 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on OKYO Ph...
Benzinga Newsdesk
Wednesday, October 23, 2024
OKYO Pharma shares are trading higher after t...
Benzinga Newsdesk
OKYO Pharma Doses First Patient In Clinical T...
Benzinga Newsdesk
Wednesday, October 16, 2024
HC Wainwright & Co. Reiterates Buy on OKYO Ph...
Benzinga Newsdesk
OKYO Pharma Announced That Screening And Recr...
Benzinga Newsdesk
Tuesday, September 10, 2024
OKYO Pharma Chairman Gabriele Cerrone Acquire...
Benzinga Newsdesk
Tuesday, August 27, 2024
OKYO Pharma shares are trading higher after t...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on OKYO Ph...
Benzinga Newsdesk
OKYO Pharma Secures US Patent Covering OK-101...
Benzinga Newsdesk
Monday, August 26, 2024
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, August 23, 2024
OKYO Says Panetta Partners, Entity Related To...
Benzinga Newsdesk
Wednesday, August 21, 2024
OKYO Pharma Announced That It Has Been Notifi...
Benzinga Newsdesk
Tuesday, August 06, 2024
OKYO Pharma Granted European Patent Enhancing...
Benzinga Newsdesk
Friday, July 12, 2024
HC Wainwright & Co. Reiterates Buy on OKYO Ph...
Benzinga Newsdesk
Thursday, July 11, 2024
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
OKYO Pharma shares are trading higher after t...
Benzinga Newsdesk
OKYO Pharma Plans To Advance OK-101 Into Phas...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on OKYO Ph...
Benzinga Newsdesk
Wednesday, July 10, 2024
OKYO Pharma Announces Categorical Data From O...
Benzinga Newsdesk
Monday, March 25, 2024
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, March 22, 2024
Relief For Dry Eye Disease? OKYO Pharma's Candidate Shows Durable Pain Relief In Mid-Stage Study
Vandana Singh
HC Wainwright & Co. Maintains Buy on OKYO Pha...
Benzinga Newsdesk
OKYO Pharma shares are trading higher after t...
Benzinga Newsdesk
OKYO Pharma Says OK-101 Achieves Statistical ...
Benzinga Newsdesk
Friday, March 01, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Monday, February 12, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
The FDA Has Cleared Okyo Pharma's OK-101 As I...
Benzinga Newsdesk
Monday, January 08, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
HC Wainwright & Co. Maintains Buy on OKYO Pha...
Benzinga Newsdesk
Okyo Pharma Reports Safety And Efficacy Resul...
Benzinga Newsdesk
Tuesday, December 05, 2023
HC Wainwright & Co. Reiterates Buy on OKYO Ph...
Benzinga Newsdesk
Monday, December 04, 2023
OKYO Pharma Announces Last Patient Enrolled I...
Benzinga Newsdesk
Thursday, November 02, 2023
HC Wainwright & Co. Initiates Coverage On OKY...
Benzinga Newsdesk
Tuesday, October 31, 2023
OKYO Pharma Announces $5.84M Cash Raise and P...
Benzinga Newsdesk
Monday, October 09, 2023
OKYO Pharma Reports Filing Of An Investigatio...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
